CASSAVA SCIENCES INC. - COMMON STOCK

2.5000

24-February-25 16:45:00

15 minutes delayed

Stocks

-0.0500

-1.96%

Today's range

2.4900 - 2.6200

ISIN

N/A

Source

NASDAQ

Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Clinical Program in Alzheimer’s Disease

08 Feb 2021 08:30:00 By Nasdaq GlobeNewswire
Cassava Sciences’ Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study

02 Feb 2021 08:30:00 By Nasdaq GlobeNewswire
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer

04 Jan 2021 08:30:00 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.